The Parkinson’s Foundation has announced the expansion of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative offering genetic testing and counseling for people with Parkinson’s disease (PD) at no cost.

Shares of Voyager Therapeutics dropped more than 12 percent as investors reacted negatively to an announcement that Neurocrine Biosciences is terminating a Parkinson’s disease collaboration between the two companies.